Clinical Research, Pharma & Healthcare FinancingAssertio to Be Acquired by Garda TherapeuticsBusiness WireApril 9, 2026April 10, 2026 by Business WireApril 9, 2026April 10, 2026016 All-Cash Tender Offer of $18 per share – or $125.1 Million – Plus Contingent Value Right Tender Offer Price Represents 34.6% Premium to Unaffected Price...
